Evidence map›Paper›PMID 35636149›Full record

ArticleSleep medicine2022

Effect of positive airway pressure therapy of obstructive sleep apnea on circulating Angiopoietin-2.

Daniel J Gottlieb, David J Lederer, John S Kim, Russell P Tracy, Su Gao, Susan Redline, Sanja Jelic

Open access · greenAbstract read
In one paragraph

Article in Sleep medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Obstructive Sleep Apnea Endophenotypes.Sleep science (Sao Paulo, Brazil) · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Daniel J GottliebMedical Service, VA Boston Healthcare System, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA. Electronic address: djgottlieb@partners.org.
David J LedererRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
John S KimUniversity of Virginia School of Medicine, Charlottesville, VA, USA.
Russell P TracyUniversity of Vermont Larner College of Medicine, Colchester, VT, USA.
Su GaoColumbia University Medical Center, New York, NY, USA.
Susan RedlineBrigham & Women's Hospital, Boston, MA, USA.
Sanja JelicColumbia University Medical Center, New York, NY, USA.
Brigham and Women's Hospital · USColumbia University Irving Medical Center · USRegeneron (United States) · USUniversity of Vermont · USUniversity of Virginia · US

Funding

Phenotypic and Molecular Signatures for Sleep Apnea and Related MorbiditiesR35HL135818 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI REDLINE, SUSAN S. · 2017 to 2023
$7.2M
Vascular endothelial dysfunction in sleep apneaR01HL106041 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JELIC, SANJA · 2011 to 2025
$6.6M
PHASE II TRIAL OF SLEEP APNEA TREATMENT TO REDUCE CARDIOVASCULAR MORBIDITYRC2HL101417 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI REDLINE, SUSAN S. · 2009 to 2010
$4.4M
Obstructive Sleep Apnea and Subclinical Lung Injury in Health and DiseaseR01HL137234 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOTTLIEB, DANIEL J, JELIC, SANJA · 2018 to 2021
$3.2M
A Planning Study: Sleep Apnea Intervention for Cardiovascular Disease ReductionU34HL105277 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MITTLEMAN, MURRAY A, REDLINE, SUSAN S. · 2010 to 2012
$2.5M
Role of polyunsaturated fatty acids in pulmonary fibrosisK23HL150301 · NHLBI · UNIVERSITY OF VIRGINIA · PI KIM, JOHN S · 2021 to 2025
$858k
NHLBI NIH HHS K23 HL150301NHLBI NIH HHS R01 HL106041NHLBI NIH HHS R01 HL137234NHLBI NIH HHS R35 HL135818NHLBI NIH HHS RC2 HL101417NHLBI NIH HHS U34 HL105277
6 · The paper itself

Abstract

backgroundObstructive sleep apnea (OSA) has been identified as a possible contributor to interstitial lung disease. While positive airway pressure (PAP) is effective therapy for OSA, it causes large increases in lung volumes during the night that are potentially deleterious, analogous to ventilator-induced lung injury, although this has not been previously studied. The goal of this study was to assess the impact of PAP therapy on four biomarkers of alveolar epithelial and endothelial injury and extracellular matrix remodeling in patients with OSA.

methodsIn 82 patients with moderate to severe OSA who were adherent to PAP therapy, surfactant protein D, osteopontin, angiopoietin-2, and matrix metalloprotease-7 were measured by ELISA in serum samples collected before and 3- to 6-months after initiation of PAP therapy.

resultsAn increase in angiopoietin-2 level of 0.28 ng/mL following PAP therapy was observed (p = 0.007). This finding was replicated in an independent sample of OSA patients. No significant change was detected in surfactant protein D, osteopontin, or matrix metalloprotease-7.

conclusionsThis finding raises concern for a possible adverse impact of PAP therapy on vascular endothelium.

Indexed as

Angiopoietin-2Continuous Positive Airway PressureSleep Apnea, ObstructiveHumansMetalloproteasesOsteopontinPulmonary Surfactant-Associated Protein DAngiopoietin-2MetalloproteasesOsteopontinPulmonary Surfactant-Associated Protein DAngiopoietin-2Lung injuryObstructive sleep apneaPositive airway pressure

Identifiers

PMID35636149
PMCPMC9813950
OpenAlexW4280644179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.